<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table I.</label>
 <caption>
  <p>Literature data on Tilorone antiviral activity.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>
     <bold>Virus</bold>
    </th>
    <th>
     <bold>Genus</bold>
    </th>
    <th>
     <bold>Type</bold>
    </th>
    <th>
     <bold>Efficacy</bold>
    </th>
    <th>
     <bold>Reference</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Mengo virus</td>
    <td>cardiovirus</td>
    <td>+ ssRNA</td>
    <td>80% survival in mice at 250 mg/kg single oral dose</td>
    <td>(
     <xref ref-type="bibr" rid="CR12">12</xref>)
    </td>
   </tr>
   <tr>
    <td>Semliki Forest</td>
    <td>alphavirus</td>
    <td>+ ssRNA</td>
    <td>100% survival in mice at 250 mg/kg single oral dose</td>
    <td>(
     <xref ref-type="bibr" rid="CR12">12</xref>)
    </td>
   </tr>
   <tr>
    <td>Vesicular stomatitis</td>
    <td>vesiculovirus</td>
    <td>-ssRNA</td>
    <td>20% survival but delayed time to death with two 250 mg/kg doses</td>
    <td>(
     <xref ref-type="bibr" rid="CR12">12</xref>)
    </td>
   </tr>
   <tr>
    <td>Encephalomyocarditis virus (EMCV)</td>
    <td>cardiovirus</td>
    <td>+ ssRNA</td>
    <td>80% survival in mice at 250 mg/kg single oral dose</td>
    <td>(
     <xref ref-type="bibr" rid="CR12">12</xref>)
    </td>
   </tr>
   <tr>
    <td>Influenza B</td>
    <td>Betainfluenza virus</td>
    <td>-ssRNA</td>
    <td>50% survival in mice at 250 mg/kg single oral dose</td>
    <td>(
     <xref ref-type="bibr" rid="CR12">12</xref>)
    </td>
   </tr>
   <tr>
    <td>Influenza A/Equine-1</td>
    <td>Alphainfluenza virus</td>
    <td>-ssRNA</td>
    <td>40% survival in mice at 250 mg/kg single oral dose</td>
    <td>(
     <xref ref-type="bibr" rid="CR12">12</xref>)
    </td>
   </tr>
   <tr>
    <td>Influenza A/Jap/305</td>
    <td>Alphainfluenza virus</td>
    <td>-ssRNA</td>
    <td>30% survival in mice at 250 mg/kg single oral dose</td>
    <td>(
     <xref ref-type="bibr" rid="CR12">12</xref>)
    </td>
   </tr>
   <tr>
    <td>Herpes simplex virus 1</td>
    <td>simplexvirus</td>
    <td>dsDNA</td>
    <td>45% survival in mice at 250 mg/kg oral doses for 7 days</td>
    <td>(
     <xref ref-type="bibr" rid="CR12">12</xref>)
    </td>
   </tr>
   <tr>
    <td>West Nile virus</td>
    <td>flavivirus</td>
    <td>+ ssRNA</td>
    <td>46% lethality protection at 10 mg/kg</td>
    <td>(
     <xref ref-type="bibr" rid="CR19">19</xref>)
    </td>
   </tr>
   <tr>
    <td>MERS</td>
    <td>Betacoronavirus</td>
    <td>+ ssRNA</td>
    <td>EC
     <sub>50</sub> 10.56 μM, CC
     <sub>50</sub> &gt; 20 μM
    </td>
    <td>(
     <xref ref-type="bibr" rid="CR18">18</xref>)
    </td>
   </tr>
   <tr>
    <td>VEEV</td>
    <td>Alphavirus</td>
    <td>+ ssRNA</td>
    <td>1 log drop of virus titer at 25 mg/ml 
     <italic>in vitro</italic>
    </td>
    <td>(
     <xref ref-type="bibr" rid="CR20">20</xref>)
    </td>
   </tr>
   <tr>
    <td>EMCV</td>
    <td>cardiovirus</td>
    <td>+ ssRNA</td>
    <td>1 log drop of virus titer at 25 mg/ml 
     <italic>in vitro</italic>
    </td>
    <td>(
     <xref ref-type="bibr" rid="CR20">20</xref>)
    </td>
   </tr>
   <tr>
    <td>VEEV</td>
    <td>Alphavirus</td>
    <td>+ ssRNA</td>
    <td>100% survival in mice at 250 mg/kg</td>
    <td>(
     <xref ref-type="bibr" rid="CR21">21</xref>)
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
